359 related articles for article (PubMed ID: 29241936)
1. Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: A case study.
Ijuin A; Yoshikata H; Asano R; Tsuburai T; Kikuchi R; Sakakibara H
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):863-866. PubMed ID: 29241936
[TBL] [Abstract][Full Text] [Related]
2. Case report: Teriparatide treatment in a case of severe pregnancy -and lactation- associated osteoporosis.
Lampropoulou-Adamidou K; Trovas G; Stathopoulos IP; Papaioannou NA
Hormones (Athens); 2012; 11(4):495-500. PubMed ID: 23422774
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy and Lactation-Associated Osteoporosis Successfully Treated with Romosozumab: A Case Report.
Kaneuchi Y; Iwabuchi M; Hakozaki M; Yamada H; Konno SI
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676643
[TBL] [Abstract][Full Text] [Related]
4. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures.
Choe EY; Song JE; Park KH; Seok H; Lee EJ; Lim SK; Rhee Y
J Bone Miner Metab; 2012 Sep; 30(5):596-601. PubMed ID: 22105654
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of severe pregnancy and lactation-related osteoporosis with teriparatide: case report and review of the literature.
Polat SB; Evranos B; Aydin C; Cuhaci N; Ersoy R; Cakir B
Gynecol Endocrinol; 2015 Jul; 31(7):522-5. PubMed ID: 25893268
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis.
Li LJ; Zhang J; Gao P; Lv F; Song YW; Chang XY; Zhao DC; Wang O; Jiang Y; Xing XP; Xia WB; Li M
Clin Rheumatol; 2018 Nov; 37(11):3141-3150. PubMed ID: 29946989
[TBL] [Abstract][Full Text] [Related]
7. Effects of bone remodeling agents following teriparatide treatment.
Burkard D; Beckett T; Kourtjian E; Messingschlager C; Sipahi R; Padley M; Stubbart J
Osteoporos Int; 2018 Jun; 29(6):1351-1357. PubMed ID: 29541794
[TBL] [Abstract][Full Text] [Related]
8. Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).
Sugimoto T; Matsumoto T; Hosoi T; Miki T; Gorai I; Yoshikawa H; Tanaka Y; Tanaka S; Fukunaga M; Sone T; Nakano T; Ito M; Matsui S; Yoneda T; Takami H; Watanabe K; Osakabe T; Okubo N; Shiraki M; Nakamura T
Osteoporos Int; 2015 Feb; 26(2):765-74. PubMed ID: 25403903
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of denosumab on back pain-related disability and quality-of-life in patients with vertebral fragility fractures.
Moretti A; de Sire A; Curci C; Toro G; Gimigliano F; Iolascon G
Curr Med Res Opin; 2019 Jan; 35(1):151-155. PubMed ID: 30406685
[No Abstract] [Full Text] [Related]
10. At least one cyclic teriparatide administration can be helpful to delay initial onset of a new osteoporotic vertebral compression fracture.
Suk KS; Lee HM; Moon SH; Kim HJ; Kim HS; Park JO; Lee BH
Yonsei Med J; 2014 Nov; 55(6):1576-83. PubMed ID: 25323894
[TBL] [Abstract][Full Text] [Related]
11. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
Leder BZ; Tsai JN; Uihlein AV; Wallace PM; Lee H; Neer RM; Burnett-Bowie SA
Lancet; 2015 Sep; 386(9999):1147-55. PubMed ID: 26144908
[TBL] [Abstract][Full Text] [Related]
12. Approach to the patient with pregnancy and lactation-associated osteoporosis: A case report and a review of the literature.
Zhang M; Chen P; Li B; Du J; Pan T; Chen J
Medicine (Baltimore); 2017 Nov; 96(46):e8671. PubMed ID: 29145296
[TBL] [Abstract][Full Text] [Related]
13. Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
Jeon S; Yu D; Kim S; Kim SW; Jeon I
Osteoporos Int; 2024 May; 35(5):795-804. PubMed ID: 38261013
[TBL] [Abstract][Full Text] [Related]
14. A case of pregnancy and lactation associated osteoporosis in the third pregnancy; robust response to teriparatide despite delayed administration.
Cerit ET; Cerit M
Bone Rep; 2020 Dec; 13():100706. PubMed ID: 32884982
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Teriparatide for the Treatment of Multiple Spontaneous Clinical Vertebral Fractures after Discontinuation of Denosumab in a Female Patient with Rheumatoid Arthritis: A Case Report.
Mori Y; Izumiyama T; Mori N; Aizawa T
Tohoku J Exp Med; 2021 May; 254(1):57-61. PubMed ID: 34053968
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of 4-year denosumab treatment alone or in combination with teriparatide in Japanese postmenopausal osteoporotic women.
Suzuki T; Nakamura Y; Kato H
Mod Rheumatol; 2019 Jul; 29(4):676-681. PubMed ID: 30217118
[No Abstract] [Full Text] [Related]
17. Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis.
Zhang L; Pang Y; Shi Y; Xu M; Xu X; Zhang J; Ji L; Zhao D
Menopause; 2015 Sep; 22(9):1021-5. PubMed ID: 25944523
[TBL] [Abstract][Full Text] [Related]
18. Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS).
Ljunggren O; Benhamou CL; Dekker J; Kapetanos G; Kocjan T; Langdahl BL; Napoli N; Petto H; Nikolić T; Lindh E
Curr Med Res Opin; 2014 Aug; 30(8):1607-16. PubMed ID: 24720366
[TBL] [Abstract][Full Text] [Related]
19. Effect of Time of Administration of Teriparatide on Bone Mineral Density in Glucocorticoid-Induced Osteoporosis.
Mastaglia SR
J Clin Densitom; 2017; 20(4):513-515. PubMed ID: 28579148
[TBL] [Abstract][Full Text] [Related]
20. Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis.
Mana DL; Zanchetta MB; Zanchetta JR
Osteoporos Int; 2017 Apr; 28(4):1491-1494. PubMed ID: 27966106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]